← 產業報告目錄
Tasimelteon Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 107報告編號 APO-f3a2fb09c7
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Tasimelteon market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tasimelteon is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tasimelteon is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Tasimelteon is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tasimelteon include Vanda Pharmaceuticals and Teva Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tasimelteon market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tasimelteon Market by Company
Vanda Pharmaceuticals
Teva Pharmaceuticals
Tasimelteon Segment by Type
Original Drug
Generic Drug
Tasimelteon Segment by Application
Hospital
Clinic
Other
Tasimelteon Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tasimelteon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tasimelteon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tasimelteon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tasimelteon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tasimelteon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tasimelteon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Tasimelteon Market Size (2021-2032)
2.2.2 Global Tasimelteon Sales (2021-2032)
2.2.3 Global Tasimelteon Market Average Price (2021-2032)
2.3 Tasimelteon by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Original Drug
2.3.3 Generic Drug
2.4 Tasimelteon by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Tasimelteon Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Tasimelteon Sales (K Units) of Manufacturers (2021-2026)
3.3 Global Tasimelteon Revenue of Manufacturers (2021-2026)
3.4 Global Tasimelteon Average Price by Manufacturers (2021-2026)
3.5 Global Tasimelteon Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Tasimelteon, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Tasimelteon, Product Type & Application
3.8 Global Manufacturers of Tasimelteon, Established Date
3.9 Global Tasimelteon Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Vanda Pharmaceuticals
4.1.1 Vanda Pharmaceuticals Company Information
4.1.2 Vanda Pharmaceuticals Business Overview
4.1.3 Vanda Pharmaceuticals Tasimelteon Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Vanda Pharmaceuticals Tasimelteon Product Portfolio
4.1.5 Vanda Pharmaceuticals Recent Developments
4.2 Teva Pharmaceuticals
4.2.1 Teva Pharmaceuticals Company Information
4.2.2 Teva Pharmaceuticals Business Overview
4.2.3 Teva Pharmaceuticals Tasimelteon Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Teva Pharmaceuticals Tasimelteon Product Portfolio
4.2.5 Teva Pharmaceuticals Recent Developments
5 Global Tasimelteon Market Scenario by Region
5.1 Global Tasimelteon Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Tasimelteon Sales by Region: 2021-2032
5.2.1 Global Tasimelteon Sales by Region: 2021-2026
5.2.2 Global Tasimelteon Sales by Region: 2027-2032
5.3 Global Tasimelteon Revenue by Region: 2021-2032
5.3.1 Global Tasimelteon Revenue by Region: 2021-2026
5.3.2 Global Tasimelteon Revenue by Region: 2027-2032
5.4 North America Tasimelteon Market Facts & Figures by Country
5.4.1 North America Tasimelteon Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Tasimelteon Sales by Country (2021-2032)
5.4.3 North America Tasimelteon Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Tasimelteon Market Facts & Figures by Country
5.5.1 Europe Tasimelteon Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Tasimelteon Sales by Country (2021-2032)
5.5.3 Europe Tasimelteon Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Tasimelteon Market Facts & Figures by Country
5.6.1 Asia Pacific Tasimelteon Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Tasimelteon Sales by Country (2021-2032)
5.6.3 Asia Pacific Tasimelteon Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Tasimelteon Market Facts & Figures by Country
5.7.1 South America Tasimelteon Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Tasimelteon Sales by Country (2021-2032)
5.7.3 South America Tasimelteon Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Tasimelteon Market Facts & Figures by Country
5.8.1 Middle East and Africa Tasimelteon Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Tasimelteon Sales by Country (2021-2032)
5.8.3 Middle East and Africa Tasimelteon Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Tasimelteon Sales by Type (2021-2032)
6.1.1 Global Tasimelteon Sales by Type (2021-2032) & (K Units)
6.1.2 Global Tasimelteon Sales Market Share by Type (2021-2032)
6.2 Global Tasimelteon Revenue by Type (2021-2032)
6.2.1 Global Tasimelteon Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Tasimelteon Revenue Market Share by Type (2021-2032)
6.3 Global Tasimelteon Price by Type (2021-2032)
7 Segment by Application
7.1 Global Tasimelteon Sales by Application (2021-2032)
7.1.1 Global Tasimelteon Sales by Application (2021-2032) & (K Units)
7.1.2 Global Tasimelteon Sales Market Share by Application (2021-2032)
7.2 Global Tasimelteon Revenue by Application (2021-2032)
7.2.1 Global Tasimelteon Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Tasimelteon Revenue Market Share by Application (2021-2032)
7.3 Global Tasimelteon Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Tasimelteon Value Chain Analysis
8.1.1 Tasimelteon Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Tasimelteon Production Mode & Process
8.2 Tasimelteon Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Tasimelteon Distributors
8.2.3 Tasimelteon Customers
9 Global Tasimelteon Analyzing Market Dynamics
9.1 Tasimelteon Industry Trends
9.2 Tasimelteon Industry Drivers
9.3 Tasimelteon Industry Opportunities and Challenges
9.4 Tasimelteon Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Tasimelteon Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Tasimelteon Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Tasimelteon Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Tasimelteon Revenue of Manufacturers (2021-2026)
Table 9. Global Tasimelteon Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Tasimelteon Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Tasimelteon Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Tasimelteon, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Tasimelteon, Product Type & Application
Table 14. Global Tasimelteon Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Tasimelteon by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Vanda Pharmaceuticals Company Information
Table 19. Vanda Pharmaceuticals Business Overview
Table 20. Vanda Pharmaceuticals Tasimelteon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Vanda Pharmaceuticals Tasimelteon Product Portfolio
Table 22. Vanda Pharmaceuticals Recent Developments
Table 23. Teva Pharmaceuticals Company Information
Table 24. Teva Pharmaceuticals Business Overview
Table 25. Teva Pharmaceuticals Tasimelteon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Teva Pharmaceuticals Tasimelteon Product Portfolio
Table 27. Teva Pharmaceuticals Recent Developments
Table 28. Global Tasimelteon Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 29. Global Tasimelteon Sales by Region (2021-2026) & (K Units)
Table 30. Global Tasimelteon Sales Market Share by Region (2021-2026)
Table 31. Global Tasimelteon Sales by Region (2027-2032) & (K Units)
Table 32. Global Tasimelteon Sales Market Share by Region (2027-2032)
Table 33. Global Tasimelteon Revenue by Region (2021-2026) & (US$ Million)
Table 34. Global Tasimelteon Revenue Market Share by Region (2021-2026)
Table 35. Global Tasimelteon Revenue by Region (2027-2032) & (US$ Million)
Table 36. Global Tasimelteon Revenue Market Share by Region (2027-2032)
Table 37. North America Tasimelteon Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 38. North America Tasimelteon Sales by Country (2021-2026) & (K Units)
Table 39. North America Tasimelteon Sales by Country (2027-2032) & (K Units)
Table 40. North America Tasimelteon Revenue by Country (2021-2026) & (US$ Million)
Table 41. North America Tasimelteon Revenue by Country (2027-2032) & (US$ Million)
Table 42. Europe Tasimelteon Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Europe Tasimelteon Sales by Country (2021-2026) & (K Units)
Table 44. Europe Tasimelteon Sales by Country (2027-2032) & (K Units)
Table 45. Europe Tasimelteon Revenue by Country (2021-2026) & (US$ Million)
Table 46. Europe Tasimelteon Revenue by Country (2027-2032) & (US$ Million)
Table 47. Asia Pacific Tasimelteon Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 48. Asia Pacific Tasimelteon Sales by Country (2021-2026) & (K Units)
Table 49. Asia Pacific Tasimelteon Sales by Country (2027-2032) & (K Units)
Table 50. Asia Pacific Tasimelteon Revenue by Country (2021-2026) & (US$ Million)
Table 51. Asia Pacific Tasimelteon Revenue by Country (2027-2032) & (US$ Million)
Table 52. South America Tasimelteon Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 53. South America Tasimelteon Sales by Country (2021-2026) & (K Units)
Table 54. South America Tasimelteon Sales by Country (2027-2032) & (K Units)
Table 55. South America Tasimelteon Revenue by Country (2021-2026) & (US$ Million)
Table 56. South America Tasimelteon Revenue by Country (2027-2032) & (US$ Million)
Table 57. Middle East and Africa Tasimelteon Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 58. Middle East and Africa Tasimelteon Sales by Country (2021-2026) & (K Units)
Table 59. Middle East and Africa Tasimelteon Sales by Country (2027-2032) & (K Units)
Table 60. Middle East and Africa Tasimelteon Revenue by Country (2021-2026) & (US$ Million)
Table 61. Middle East and Africa Tasimelteon Revenue by Country (2027-2032) & (US$ Million)
Table 62. Global Tasimelteon Sales by Type (2021-2026) & (K Units)
Table 63. Global Tasimelteon Sales by Type (2027-2032) & (K Units)
Table 64. Global Tasimelteon Sales Market Share by Type (2021-2026)
Table 65. Global Tasimelteon Sales Market Share by Type (2027-2032)
Table 66. Global Tasimelteon Revenue by Type (2021-2026) & (US$ Million)
Table 67. Global Tasimelteon Revenue by Type (2027-2032) & (US$ Million)
Table 68. Global Tasimelteon Revenue Market Share by Type (2021-2026)
Table 69. Global Tasimelteon Revenue Market Share by Type (2027-2032)
Table 70. Global Tasimelteon Price by Type (2021-2026) & (US$/Unit)
Table 71. Global Tasimelteon Price by Type (2027-2032) & (US$/Unit)
Table 72. Global Tasimelteon Sales by Application (2021-2026) & (K Units)
Table 73. Global Tasimelteon Sales by Application (2027-2032) & (K Units)
Table 74. Global Tasimelteon Sales Market Share by Application (2021-2026)
Table 75. Global Tasimelteon Sales Market Share by Application (2027-2032)
Table 76. Global Tasimelteon Revenue by Application (2021-2026) & (US$ Million)
Table 77. Global Tasimelteon Revenue by Application (2027-2032) & (US$ Million)
Table 78. Global Tasimelteon Revenue Market Share by Application (2021-2026)
Table 79. Global Tasimelteon Revenue Market Share by Application (2027-2032)
Table 80. Global Tasimelteon Price by Application (2021-2026) & (US$/Unit)
Table 81. Global Tasimelteon Price by Application (2027-2032) & (US$/Unit)
Table 82. Key Raw Materials
Table 83. Raw Materials Key Suppliers
Table 84. Tasimelteon Distributors List
Table 85. Tasimelteon Customers List
Table 86. Tasimelteon Industry Trends
Table 87. Tasimelteon Industry Drivers
Table 88. Tasimelteon Industry Restraints
Table 89. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Tasimelteon Product Image
Figure 5. Global Tasimelteon Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Tasimelteon Market Size (2021-2032) & (US$ Million)
Figure 7. Global Tasimelteon Sales (2021-2032) & (K Units)
Figure 8. Global Tasimelteon Average Price (US$/Unit) & (2021-2032)
Figure 9. Original Drug Product Image
Figure 10. Generic Drug Product Image
Figure 11. Hospital Product Image
Figure 12. Clinic Product Image
Figure 13. Other Product Image
Figure 14. Global Tasimelteon Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Tasimelteon, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Tasimelteon Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Tasimelteon Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Tasimelteon Sales by Region in 2025
Figure 20. Global Tasimelteon Revenue by Region in 2025
Figure 21. North America Tasimelteon Market Size by Country in 2025
Figure 22. North America Tasimelteon Sales Market Share by Country (2021-2032)
Figure 23. North America Tasimelteon Revenue Market Share by Country (2021-2032)
Figure 24. United States Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Tasimelteon Market Size by Country in 2025
Figure 27. Europe Tasimelteon Sales Market Share by Country (2021-2032)
Figure 28. Europe Tasimelteon Revenue Market Share by Country (2021-2032)
Figure 29. Germany Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Netherlands Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Nordic Countries Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Asia Pacific Tasimelteon Market Size by Country in 2025
Figure 36. Asia Pacific Tasimelteon Sales Market Share by Country (2021-2032)
Figure 37. Asia Pacific Tasimelteon Revenue Market Share by Country (2021-2032)
Figure 38. China Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Japan Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. South Korea Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. India Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Australia Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. China Taiwan Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South America Tasimelteon Market Size by Country in 2025
Figure 47. South America Tasimelteon Sales Market Share by Country (2021-2032)
Figure 48. South America Tasimelteon Revenue Market Share by Country (2021-2032)
Figure 49. Mexico Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Brazil Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Argentina Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Middle East and Africa Tasimelteon Market Size by Country in 2025
Figure 53. Middle East and Africa Tasimelteon Sales Market Share by Country (2021-2032)
Figure 54. Middle East and Africa Tasimelteon Revenue Market Share by Country (2021-2032)
Figure 55. Turkey Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Saudi Arabia Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. UAE Tasimelteon Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Global Tasimelteon Sales Market Share by Type (2021-2032)
Figure 59. Global Tasimelteon Revenue Market Share by Type (2021-2032)
Figure 60. Global Tasimelteon Price (US$/Unit) by Type (2021-2032)
Figure 61. Global Tasimelteon Sales Market Share by Application (2021-2032)
Figure 62. Global Tasimelteon Revenue Market Share by Application (2021-2032)
Figure 63. Global Tasimelteon Price (US$/Unit) by Application (2021-2032)
Figure 64. Tasimelteon Value Chain
Figure 65. Tasimelteon Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Tasimelteon Industry Opportunities and Challenges
提及公司
Vanda PharmaceuticalsTeva Pharmaceuticals
量子訊息有限公司為 APO Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們